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Partial karyotypes showing the chromosomal translocation t(X;11)(q22;q23). 
 
Clinics and pathology 
Disease 
The chromosomal translocation t(X;11)(q22;q23) 
occurs very rarely, with only three cases of infants 
young children having been described in the literature; 
2 AML cases: a 3 years old male, diagnosed with 
AML-M2 (Harrison et al., 1998) and 2 years old female 
diagnosed with acute megakaryoblastic leukemia (FAB 
type M7) (Ribeiro et al., 1993). The one ALL case 
described in a 4 years old male had a complex 
karyotype with chromosomal translocation 
t(11;14)(q13;q32), and monosomy 22 (Soszynska et al., 
2008). Of note, the fourth AML (FAB type M2) case 
reported by Slater in a 10 months old male was shown 
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to involve the SEPTIN6 gene located on Xq24 (Slater 
et al., 2002). 
Phenotype/cell stem origin 
Suggested involvement of a pluripotent stem cell or a 
myeloid progenitor cell; myeloid lineage. 
Etiology 
No known prior exposure. 
Epidemiology 
Only 3 cases to date, sex ratio 2M/1F. 
Prognosis 
From the known data, the 3 years old male, diagnosed 
with AML-M2 remained alive in complete remission at 
97 months; the ALL patient was in complete remission 
after 39 months. 
Cytogenetics 
Note 
Breakpoints difficult to ascertain; cytogenetic 
appearance may be similar to t(X;11)(q13;q23) 





Sole abnormality in AML-M2 case, part of a 
hyperploid karyotype associated with +6, +8, +19, +21, 
+21 in a child with acute megakaryoblastic leukemia 
and complex karyotype in ALL case associated with 
t(11;14)(q13;q32), and monosomy 22, indicating that 
the t(X;11)(q22;q23) is likely to be a secondary 
anomaly to t(11;14)(q13;q32) in ALL. 
Genes involved and proteins 
Note 
The gene in Xq22 is yet unknown, it is therefore 






The MLL gene is frequently disrupted by a variety of 
chromosomal rearrangements that occur in acute 
myeloblastic leukemia (AML) and in acute 
lymphoblastic leukemia (ALL), with a peak incidence 
in infant leukemia as well as in secondary, 
topoisomerase II inhibitor-related leukemia. 
DNA/RNA 
The MLL genomic structure consists of 36 exons 
distributed over 100 kb, the mRNA of ~11.9 kb 
encodes a 3969 amino-acid nuclear protein with a 
molecular weight of of 430 kDa. 
Protein 
The MLL protein is a multi-domain molecule with 
regions of homology to diverse proteins; a major 
regulator of class I homeobox (HOX) gene expression. 




5' MLL - PARTNER GENE 3'. 
MLL translocation breakpoints cluster within an 8.3-kb 
region spanning exons 5-11; genomic breakpoint 
junction usually created on the der(11) chromosome. 
Fusion protein 
Oncogenesis 
Expression of a chimeric protein with actively 
transforming properties; altered patterns of MLL 
activity in hematopoietic stem cells resulting in 
blockage of hematopoietic maturation. 
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